Stablecoin Development Corporation

Abbott Cooper PLLC announced an investigation into potential legal claims on behalf of stockholders of Stablecoin Development Corporation, formerly NovaBay Pharmaceuticals, Inc., who held shares prior to August 19, 2025. The investigation focuses on whether the Stablecoin Development Corporation Board violated its fiduciary duties in connection with a private placement of preferred stock. Stockholders who have held shares since before that date are encouraged to contact the firm at no cost or obligation. Abbott Cooper PLLC handles cases on a contingency fee basis, meaning there is no cost to stockholders unless a recovery is obtained.